0 followers
Mythic Therapeutics’ innovative FateControl technology expands the potential of Antibody Drug Conjugates (ADCs) to destroy cancer and avoid normal cells.
Elicio Therapeutics
1 follower
Halda Therapeutics
1 follower
Tarsus Pharmaceuticals
1 follower
Bloomberg Philanthropies
2 followers
Thermo Fisher Scientific
157 followers
GRAIL
27 followers
Cytokinetics
11 followers
SpringWorks Therapeutics
5 followers
Artivion
3 followers
Benchling
18 followers
Urban Initiatives
13 followers
Explore companies